https://www.selleckchem.com/pe....ptide/bulevirtide-my
Breast cancer (BC) in women could decrease health-related quality of life (HRQoL). HRQoL becomes important to be assessed to design a relevant treatment that could improve patient outcomes. Furthermore, assessing HRQoL by measuring health state utilities becomes pivotal for health economic evaluation. This study aimed to describe the HRQoL of postmenopausal women with hormone responsive (HR+) HER2- BC using the EQ5D5L instrument in Indonesia. A cross-sectional study was conducted among 126 patients in Dr. Sardjito Hospita
Like
Comment
Share
